Bladder Cancer Clinical Trials in Tsukuba, Ibaraki
2 recruitingTsukuba, Ibaraki, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals454 enrolled77 locationsNCT06510374
Recruiting
Phase 2
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Bladder Cancer
Kyoto University Hospital30 enrolled4 locationsNCT05879653